BKG VET PHARMA ApS: Financial statements 2014
CVR: 34044341
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
BKG VET PHARMA ApS (CVR 34044341) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -120,090 and a net result of DKK -41,653 compared with DKK 92,761 the year before. Equity in the 2014 report amounted to DKK 7,606,668. The solvency ratio was 83.5%.
- Gross Profit
- DKK -120,090
- Profit/Loss
- DKK -41,653
- Equity
- DKK 7,606,668
- Total Assets
- DKK 9,110,514
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -120 t. | -42 t. | 7.6 mio. | - |
| 2013 | - | -89 t. | 93 t. | 7.6 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of July 4, 2014, Rasmus Schmiegelow is registered as chairman of BKG VET PHARMA ApS.
As of June 24, 2014, Morten Stadil has stepped down as chairman of BKG VET PHARMA ApS.
BKG VET PHARMA ApS has published its annual report for 2013. Gross profit came to DKK -88,785, and the net result was DKK 92,761.
As of April 22, 2014, Jan Mousing has joined the board of directors of BKG VET PHARMA ApS.
As of April 22, 2014, Nicolaj Henrik Nørgaard has left the board of directors of BKG VET PHARMA ApS.
About BKG VET PHARMA ApS
BKG VET PHARMA ApS was a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2011. The company has been dissolved on 31 March 2020. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees (2017). In 2018, the company reported a gross profit of DKK -36,050 and a net result of DKK -94,791 compared with DKK -329,327 the year before. Equity in the 2018 report amounted to DKK 225,768.